in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (2 weeks ago)
RT @EU_ToxRisk: The EU-ToxRisk NAM-based Testing Commercialization Platform presented during the @EU_ToxRisk Open Symposium, Feb 12, 2020 i…
Edelweiss Connect (2 weeks ago)
RT @Biopredic_Intl: We are glad to announce the launch of the new HepaRG #logo !! Worldwide recognized and quite unique human hepatic stem…
Edelweiss Connect (3 weeks ago)
The SafeDESIgn imaging-based toxicity reporter platform for chemical safety assessment #SaferWorldbyDesign… https://t.co/7xeN1d6w6t
Edelweiss Connect (5 weeks ago)
The latest #OpenTox webinar focused on #AOPs current trends and developments, presented by Tatyana Doktorova https://t.co/ZKj5PivfiN
Edelweiss Connect (5 weeks ago)
RT @barryhardy: Tatyana Doktorova will discuss current trends and developments in Adverse Outcome Pathways as exemplified by case studies (…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA